Ankang Zhengda Pharmaceutical

Ankang Zhengda Pharmaceutical Co., Ltd. is a prominent Chinese pharmaceutical company and a key subsidiary of the Chia Tai Pharmaceutical Group. Located in the Ankang High-tech Industrial Development Zone, the company specializes in the modernization of Traditional Chinese Medicine, particularly in the field of cardiovascular and cerebrovascular health. Its core business revolves around the research, development, and large-scale production of Ginkgo Biloba extract-based medications, marketed under the well-known Tianxin brand. The company maintains advanced GMP-certified manufacturing facilities for injections, capsules, and tablets. Ankang Zhengda is recognized as a leading enterprise in Shaanxi Province, integrating natural product extraction with modern pharmaceutical technology. Its products are widely distributed across China to treat conditions such as coronary heart disease and cerebral infarction.